Skip to main content
Contact Us
Subscribe
E-Edition
49°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about multiple myeloma
Recent news which mentions multiple myeloma
Pack Health & UCSF Publish Usability Study of Digital Coaching for Patients Undergoing SCT in JMIR
April 13, 2022
Tags
Cancer
chronic disease management
digital health coaching
From
PRUnderground
EMA's CHMP Clears Janssen, Legend's Multiple Myeloma CAR-T Therapy
March 25, 2022
Tickers
JNJ
LEGN
Tags
European Medicines Agency
LEGN
General
From
Benzinga
Allogene's Preclinical Data Show Healthy Donor-Derived Allogeneic CAR T Cells Have Better Immune Fitness, Killing Activity
March 23, 2022
Tickers
ALLO
SWTX
Tags
Preclinical Phase
Market News
News
From
Benzinga
Bristol Myers, 2seventy Pull Plug On Multiple Myeloma CAR-T As Abecma Sales Gain Momentum
January 11, 2022
Tickers
BMY
TSVT
Tags
Market News
BMY
multiple myeloma
From
Benzinga
Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients
December 13, 2021
Tickers
BMY
JNJ
SNY
TAK
Tags
SNY
Briefs
News
From
Benzinga
Harpoon Shares Jump After Early Data From BCMA-Targeting Myeloma Candidate At ASH Meet
December 13, 2021
Tickers
HARP
Tags
Market News
ASH21
Trading Ideas
From
Benzinga
JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma
December 13, 2021
Tickers
JNJ
LEGN
Tags
multiple myeloma
Health Care
JNJ
From
Benzinga
AbbVie, SpringWorks Join Forces To Conduct Multiple Myeloma Combo Therapy Trial
December 10, 2021
Tickers
ABBV
SWTX
Tags
SWTX
General
Benzinga
From
Benzinga
iTeos Posts New Preclinical Data For Anti-TIGIT Antibody At ASH 2021
December 10, 2021
Tickers
ITOS
Tags
Biotech
Benzinga
ITOS
From
Benzinga
Why Are Legend Biotech Shares Gaining Today?
December 07, 2021
Tickers
LEGN
Tags
News
multiple myeloma
Trading Ideas
From
Benzinga
Janssen's Subcutaneous Darzalex Combo Wins FDA Approval For Pretreated Multiple Myeloma
December 02, 2021
Tickers
AMGN
HALO
JNJ
Tags
HALO
Briefs
Biotech
From
Benzinga
Gracell Biotech Stock Jumps On Orphan Drug Tag For Multiple Myeloma CAR-T Cell Therapy
November 19, 2021
Tickers
GRCL
Tags
Health Care
Trading Ideas
multiple myeloma
From
Benzinga
Poseida's Fully Allogeneic CAR-T Product Enters Human Trial For Multiple Myeloma
August 30, 2021
Tickers
PSTX
Tags
Biotech
Movers
Benzinga
From
Benzinga
UK's NICE Rejects Johnson & Johnson's Darzalex Regime For Newly Diagnosed Myeloma
August 30, 2021
Tickers
BMY
JNJ
TAK
TKPHF
Tags
Biotech
Benzinga
Government
From
Benzinga
Europe Approves Bristol Myers' BCMA-Targeted Multiple Myeloma Immunotherapy
August 19, 2021
Tickers
BMY
Tags
Market News
European Medicines Agency
FDA
From
Benzinga
Allogene's BCMA-Targeted Therapy Gets US Orphan Drug Tag For Multiple Myeloma
August 12, 2021
Tickers
ALLO
Tags
Benzinga
Health Care
Biotech
From
Benzinga
C4 Therapeutics Multiple Myeloma Candidate Scores FDA Orphan Drug Tag
August 12, 2021
Tickers
CCCC
Tags
Briefs
Biotech
Benzinga
From
Benzinga
Sorrento Therapeutics To Start Testing DAR-T Cell Therapy In Multiple Myeloma Patients
August 02, 2021
Tickers
SRNE
Tags
SRNE
News
Health Care
From
Benzinga
Janssen's Darzalex Faspro Wins FDA Approval In Combination With Pomalidomide, Dexamethasone For Multiple Myeloma
July 12, 2021
Tickers
HALO
JNJ
Tags
Briefs
News
HALO
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.